An Updated Look At Glaukos
I still like the company, but the stock has now run up enough to where I no longer consider it clearly undervalued. That’s not…
I still like the company, but the stock has now run up enough to where I no longer consider it clearly undervalued. That’s not…
More Americans need to be vaccinated and may respond to an option that’s unlike what’s available, so the FDA should give Ocugen’s COVAXIN a try.
Invitation Homes is the largest publicly-traded owner of single-family homes in the U.S.
Insider buying decreased last week. Notable Insider Buys: PennyMac Financial Services, Inc., First Financial Bankshares, Inc., Lindblad Expeditions Holdings, Inc.,…
Despite Altria’s 1.8% YoY adjusted diluted EPS decline, it beat analyst expectations and acquired the remaining 20% of its business, which should prove to be a…
The impact of the Truvada patent expiry on Gilead’s revenue should be muted for 2021 and beyond. Gilead (GILD) has a strong drug portfolio and pipeline and continues…
Baker Hughes expects a recovery in oil demand, alongside a potential recovery in the global economy, in 2021. Read more here for my near-term outlook and what I…
Since 2010, emerging market central bank tightening has usually been followed by a weaker dollar and rising gold prices the next six months.
Jumia can benefit from its pan-African presence and established leadership position but needs to strike the right balance between investing in growth opportunities…
I made eight transactions during the month. I added around $8.50 in dividends going forward (after tax).